MD Anderson Cancer Center
Best therapies for relapsed diffuse large b-cell lymphoma - CNL
When diffuse large b-cell lymphoma returns after the cancer patient is initially treated, it is called relapsed diffuse large b-cell lymphoma (DLBCL). If this happens, other therapies besides the standard R-CHOP (chemotherapy drugs cyclophosphamide, doxorubicin, vincristine, and prednisone) may be successful in fighting the disease. Jason Westin, M.D., assistant professor in Lymphoma/Myeloma at MD Anderson Cancer Center, discusses these therapies, including high dose chemotherapy combined with stem cell transplantation, as well as clinical trials for relapsed diffuse large b-cell lymphoma.

Transcript Transcript     Accessibility shortcut keys (H) Shortcuts
Loading the Audio Player...

Title: Best therapies for relapsed diffuse large b-cell lymphoma - CNL
Summary: When diffuse large b-cell lymphoma returns after the cancer patient is initially treated, it is called relapsed diffuse large b-cell lymphoma (DLBCL). If this happens, other therapies besides the standard R-CHOP (chemotherapy drugs cyclophosphamide, doxorubicin, vincristine, and prednisone) may be successful in fighting the disease. Jason Westin, M.D., assistant professor in Lymphoma/Myeloma at MD Anderson Cancer Center, discusses these therapies, including high dose chemotherapy combined with stem cell transplantation, as well as clinical trials for relapsed diffuse large b-cell lymphoma.
Keywords: cnl, cancer newsline dlbcl, Relapsed diffuse large b-cell lymphoma, stem cell transplant, high dose chemotherapy, clinical trial, cancer, Jason westin
Transcript: http://www.mdanderson.org/transcripts/cancer-newsline/2014/best-therapies-for-relapsed-diffuse-large-b-cell-lymphoma-7-28-14.htm